Skip to main content
BioThera Solutions
Resources/Press

For journalists, producers, and conference programmers.

BioThera's founder is a named contributor to MISEV2023, the international consensus standard for extracellular vesicle research. He is available as an expert source on EV science, the exosome skincare market, EV biomanufacturing, and Canadian biotech. Media kit and direct contact below.

Where BioThera has been mentioned

Disciplined Entrepreneurship · 2026-10-25

Why a Biotech Founder Chose Skincare as His Beachhead: Applying DE Framework to Deep Tech

Contributed article by our founder on why BioThera chose skincare as its first commercial market, using the Disciplined Entrepreneurship framework for a deep tech venture.

BetaKit · 2026-08-11

This Ottawa scientist believes skincare is a foothold into the future of medicine

Profile of the founder and of BioThera's plan to start with a skincare application while building toward manufacturing extracellular vesicles for others.

UpNext Global · 2026-06-17

AccelerateOTT 2026: Ottawa's Founders Take a Global Stage

BioThera named among the standout companies at AccelerateOTT 2026.

Invest Ottawa · 2026-05-28

Ten Startups. One Global Stage. Meet the Founders Competing at Startup World Cup Ottawa Regional Competition

BioThera selected as one of ten finalists at the Startup World Cup Ottawa regional competition.

Ottawa Business Journal · 2026-05-06

Seven startups recognized at Bootstrap Awards

BioThera receives the Innovation Award at the Bootstrap Awards, which recognize self-funded entrepreneurs in Canada's National Capital Region.

University of Ottawa · 2026-04-01

Dr. Frederic St-Denis-Bissonnette Awarded Prestigious Fulbright Scholarship to Advance EV Biotech Commercialization at MIT

The founder's 2025–2026 Fulbright Canada Short-Term Entrepreneurship Award, hosted at MIT, and BioThera's path through the uOttawa eHub, including first place at Rally Day.

University of Ottawa · 2025-10-23

Student startups at uOttawa: Innovative anti-aging skincare

Profile of BioThera's founding in 2024 and its work on plant-derived extracellular vesicles.

Topics the founder can speak to

Frédéric St-Denis-Bissonnette, PhD, Founder & CEO. Named contributor to MISEV2023. Fulbright Canada Entrepreneurship Award (MIT). First-author publications in Journal of Extracellular Vesicles, Journal of Extracellular Biology, Langmuir, JoVE, and Nanomaterials.

Topic 01

Extracellular vesicles and the MISEV2023 consensus

Founder Frédéric St-Denis-Bissonnette is a named contributor to MISEV2023, the international consensus guidelines published by the International Society for Extracellular Vesicles. He can speak to what the field's quality standards actually require and where commercial EV products often fall short.

Topic 02

Plant-derived versus mammalian extracellular vesicles

Comparative biology, safety, scalability, and regulatory pathway for plant-derived versus mammalian-derived EVs in the context of dermocosmetic and EV-based skincare applications. Where the evidence is mature, where it is preliminary, and where it is being overstated in the EV skincare category.

Topic 03

The exosome skincare market and how to evaluate a product

Why the word "exosome" is used incorrectly on most cosmetic labels, what a defensible Certificate of Analysis looks like, and the clinician-facing five-criteria framework BioThera publishes for evaluating EV products.

Topic 04

EV biomanufacturing at scale

The infrastructure gap that has kept EV products at the bench: why isolation method changes the biomolecular corona, what a process designed to scale needs, and MISEV2023-aligned batch documentation.

Topic 05

Canadian biotech, Ottawa ecosystem, Fulbright research-to-startup pathway

St-Denis-Bissonnette received a 2025–2026 Fulbright Canada Short-Term Entrepreneurship Award, with a residency at MIT in April 2026, and is a graduate of Ottawa's research-to-startup programs. Available for stories on Canadian biotech, federal research commercialization, and the founder-as-scientist model.

Logos, headshot and approved company descriptions

The media kit has downloadable logos, the founder's headshot, company descriptions you can copy, key facts, brand colours and naming rules. All of it may be used in editorial coverage without prior approval.

Open the media kit

Pitch an interview, request an interview, or fact-check a quote

The fastest route is the contact form with press as the intent. Responses go out within one business day.

BioThera Solutions

A fully integrated extracellular vesicle company, from research and intellectual property to manufacturing, with a process designed to scale. Extracellular vesicles (EVs/exosomes) are among biology's most promising delivery systems, and we are building the infrastructure the field has been missing.

Ottawa, Ontario, Canada
477-150 Louis-Pasteur Private Ottawa, Ontario K1N 9B4 Canada
Add BioThera Solutions as a preferred source on Google

© 2026 BioThera Solutions Inc. All rights reserved.

For informational purposes only. Nothing on this website is medical advice. BioThera develops and manufactures characterized extracellular vesicles (exosomes) and, for cosmetic applications, licenses its technology exclusively to Vesera™, a skincare company and BioThera subsidiary. Vesera™ products are cosmetics and are not intended to diagnose, treat, cure, or prevent any disease. BioThera does not sell products to consumers, and its work on therapeutic applications is research only.